H.I.G. Capital Announces the Sale of US MED
Retrieved on:
Tuesday, July 27, 2021
Professional services, Health, Small business, Finance, General Health, Banking, Finance, Private equity, Earnings before interest, taxes, depreciation and amortization, Fundamental analysis, Profit, UST, Economy, H.I.G. Capital, US MED, H.I.G. Capital, Advanced Diabetes Supply, Court Square Capital Partners, US MED, H.I.G. CAPITAL, ADVANCED DIABETES SUPPLY, COURT SQUARE CAPITAL PARTNERS
"), a leading global alternative investment firm with $45 billion of equity capital under management, announced today the sale of its portfolio company, US Medical Supply (US MED or the Company), to Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners Inc.
Key Points:
- "), a leading global alternative investment firm with $45 billion of equity capital under management, announced today the sale of its portfolio company, US Medical Supply (US MED or the Company), to Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners Inc.
- Additionally, US MED implemented a robust, institutionalized compliance program and invested meaningfully in technology and automation.
- US MED grew revenue and EBITDA nearly three-fold during H.I.G.s ownership, generating an outstanding return to H.I.G.
- Capital, commented, It has been a distinct pleasure working with Bill and his team to complete the strategic transformation of US MED.